These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9362376)
1. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells. Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activator. Barrett-Bergshoeff M; Noorman F; Bos R; Rijken DC Thromb Haemost; 1997 Apr; 77(4):718-24. PubMed ID: 9134649 [TBL] [Abstract][Full Text] [Related]
3. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver. Smedsrød B; Einarsson M Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA. Otter M; Kuiper J; Bos R; Rijken DC; van Berkel TJ Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):545-50. PubMed ID: 1318035 [TBL] [Abstract][Full Text] [Related]
5. Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator. Biessen EA; van Teijlingen M; Vietsch H; Barrett-Bergshoeff MM; Bijsterbosch MK; Rijken DC; van Berkel TJ; Kuiper J Circulation; 1997 Jan; 95(1):46-52. PubMed ID: 8994415 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of mannose receptor-mediated clearance of tissue-type plasminogen activator (t-PA) by dextran: a new explanation for its antithrombotic effect. Noorman F; Barrett-Bergshoeff MM; Bekkers M; Emeis JJ; Rijken DC Thromb Haemost; 1997 Oct; 78(4):1249-54. PubMed ID: 9364993 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells. Kuiper J; Otter M; Voorschuur AH; van Zonneveld AJ; Rijken DC; van Berkel TJ Thromb Haemost; 1995 Nov; 74(5):1298-304. PubMed ID: 8607113 [TBL] [Abstract][Full Text] [Related]
9. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats. van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648 [TBL] [Abstract][Full Text] [Related]
10. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor? Camani C; Gavin O; Kruithof EK Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388 [TBL] [Abstract][Full Text] [Related]
11. Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentration. Biessen EA; Noorman F; van Teijlingen ME; Kuiper J; Barrett-Bergshoeff M; Bijsterbosch MK; Rijken DC; van Berkel TJ J Biol Chem; 1996 Nov; 271(45):28024-30. PubMed ID: 8910412 [TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator is endocytosed by mannose and galactose receptors of rat liver cells. Smedsrød B; Einarsson M; Pertoft H Thromb Haemost; 1988 Jun; 59(3):480-4. PubMed ID: 2847350 [TBL] [Abstract][Full Text] [Related]
13. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells. van der Kaaden ME; Rijken DC; Groeneveld E; van Berkel TJ; Kuiper J Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013 [TBL] [Abstract][Full Text] [Related]
14. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo. Narita M; Bu G; Herz J; Schwartz AL J Clin Invest; 1995 Aug; 96(2):1164-8. PubMed ID: 7635954 [TBL] [Abstract][Full Text] [Related]
15. Binding and degradation of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Otter M; Van Berkel TJ; Rijken DC Thromb Haemost; 1989 Sep; 62(2):667-72. PubMed ID: 2510347 [TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator. Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178 [TBL] [Abstract][Full Text] [Related]
17. Hepatic sinusoidal endothelium heterogeneity with respect to mannose receptor activity is interleukin-1 dependent. Asumendi A; Alvarez A; Martinez I; Smedsrød B; Vidal-Vanaclocha F Hepatology; 1996 Jun; 23(6):1521-9. PubMed ID: 8675173 [TBL] [Abstract][Full Text] [Related]
18. Internalization of recombinant tissue-type plasminogen activator by isolated rat hepatocytes is via coated pits. Marks GJ; Hart TK; Rush GF; Hoffstein ST; Fong KL; Bugelski PJ Thromb Haemost; 1990 Apr; 63(2):251-8. PubMed ID: 1973006 [TBL] [Abstract][Full Text] [Related]
19. Degradation of tissue-type plasminogen activator by human monocyte-derived macrophages is mediated by the mannose receptor and by the low-density lipoprotein receptor-related protein. Noorman F; Braat EA; Rijken DC Blood; 1995 Nov; 86(9):3421-7. PubMed ID: 7579446 [TBL] [Abstract][Full Text] [Related]
20. Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells. Higuchi Y; Nishikawa M; Kawakami S; Yamashita F; Hashida M Int J Pharm; 2004 Dec; 287(1-2):147-54. PubMed ID: 15541921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]